Want China Times
By: Staff Reporter
Lien Hui-hsin, daughter of Taiwan’s former vice president Lien Chan, has rebutted media
reports of her alleged involvement in the GeneHerbs pharmaceutical compound dispute, in which she received a one-year deferred prosecution in July 2014 over violations of the Pharmaceutical Affairs Act.
Lien was accused of selling questionable weight-control medicine containing cetilistat, a compound used to treat obesity but which had not been approved for use by Taiwan’s Ministry of Health and Welfare.
Fang Wen-shuan, Lien’s attorney, refuted local media claims at the time of the investigation that Lien, the largest shareholder of medicine’s distributor GeneHerbs, was the actual person in charge at the company. In an emailed statement, the representative said that “Lien never had any power to participate in the decision-making process of GeneHerbs Biotechnology as she was only an investor and an unpaid spokeswoman” and that “Lien was not a part of management nor a decision maker at the distributor and there was no evidence showing that any of the employees or shareholders of the distributor GeneHerbs had any prior knowledge of the presence of the compound cetilistat in their products, nor could any one of them have intentionally engaged in the addition or sale of any unauthorized materials.” [FULL STORY]